443 related articles for article (PubMed ID: 28096088)
1. How I treat acquired aplastic anemia.
Bacigalupo A
Blood; 2017 Mar; 129(11):1428-1436. PubMed ID: 28096088
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
Bacigalupo A; Giammarco S; Sica S
Int J Hematol; 2016 Aug; 104(2):168-74. PubMed ID: 27278666
[TBL] [Abstract][Full Text] [Related]
3. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
[TBL] [Abstract][Full Text] [Related]
7. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
Scheinberg P
Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
[TBL] [Abstract][Full Text] [Related]
8. Acquired aplastic anemia in children: incidence, prognosis and treatment options.
Locasciulli A
Paediatr Drugs; 2002; 4(11):761-6. PubMed ID: 12390048
[TBL] [Abstract][Full Text] [Related]
9. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
Kanda Y; Usuki K; Inagaki M; Ohta A; Ogasawara Y; Obara N; Kako S; Kurokawa M; Shimada N; Suzuki T; Hama A; Yamaguchi H; Nakao S; Yamazaki H
Int J Hematol; 2023 May; 117(5):660-668. PubMed ID: 36595144
[TBL] [Abstract][Full Text] [Related]
10. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.
Pulsipher MA; Young NS; Tolar J; Risitano AM; Deeg HJ; Anderlini P; Calado R; Kojima S; Eapen M; Harris R; Scheinberg P; Savage S; Maciejewski JP; Tiu RV; DiFronzo N; Horowitz MM; Antin JH
Biol Blood Marrow Transplant; 2011 Mar; 17(3):291-9. PubMed ID: 21034841
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Aplastic Anemia.
Peslak SA; Olson T; Babushok DV
Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for acquired aplastic anemia.
Georges GE; Storb R
Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
[TBL] [Abstract][Full Text] [Related]
14. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for acquired severe aplastic anemia.
Bacigalupo A
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1145-55. PubMed ID: 25459184
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for patients with severe aplastic anemia.
Bacigalupo A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
19. Single institution outcomes of treatment of severe aplastic anaemia.
Mollee P; Woodward N; Durrant S; Lockwood L; Gillett EA; Morton J; Rowell J
Intern Med J; 2001 Aug; 31(6):337-42. PubMed ID: 11529587
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of aplastic anemia.
Dezern AE; Brodsky RA
Expert Rev Hematol; 2011 Apr; 4(2):221-30. PubMed ID: 21495931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
